Article Text

PDF
Programme science research on medical male circumcision scale-up in sub-Saharan Africa
  1. Ronald H Gray1,
  2. Maria J Wawer1,
  3. Godfrey Kigozi2
  1. 1Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
  2. 2The Rakai Health Sciences Program, Entebbe, Uganda
  1. Correspondence to Dr Ronald H Gray, Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, 615 N Wolfe Street, Baltimore, MD 21205, USA; rgray{at}jhsph.edu

Abstract

Three randomised trials demonstrate that voluntary medical male circumcision (MMC) reduces male HIV acquisition by 50–60%, and post-trial surveillance has shown that the effects are long lasting. Scale-up of services has been initiated in 14 high-priority sub-Saharan African countries with high rates of HIV and low prevalence of MMC. However, circumcision coverage in the region remains low. Challenges to MMC rollout include suboptimal demand among higher-risk men, the need to expand access and reduce costs of MMC through personnel task shifting and task sharing, assuring and maintaining a high quality of service provision, and the testing and introduction of non-surgical devices. In addition, early infant male circumcision has not been adequately evaluated in Africa. Here, we describe challenges to implementation and discuss the ongoing and future role of implementation and programme science in addressing such challenges.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.